Cargando…
A clustering method to identify who benefits most from the treatment group in clinical trials
In randomized controlled trials (RCTs), the most compelling need is to determine whether the treatment condition was more effective than control. However, it is generally recognized that not all participants in the treatment group of most clinical trials benefit equally. While subgroup analyses are...
Autores principales: | Lee, Beom S., Sen, Pranab K., Park, Nan S., Boothroyd, Roger A., Peters, Roger H., Chiriboga, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346035/ https://www.ncbi.nlm.nih.gov/pubmed/25750814 http://dx.doi.org/10.1080/21642850.2014.924857 |
Ejemplares similares
-
Who benefits most?
por: Van Diermen, L.
Publicado: (2021) -
Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?
por: Fisher, David J, et al.
Publicado: (2017) -
Identifying Participants Who Would Benefit the Most from an Adult Food-literacy Program
por: Begley, Andrea, et al.
Publicado: (2019) -
Who benefits most from Lyon’s bike sharing system?
por: Cambe, Jordan, et al.
Publicado: (2020) -
Community Outreach for Navajo People Living with Diabetes: Who Benefits Most?
por: Trevisi, Letizia, et al.
Publicado: (2020)